Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

February 2014

Pharmacy Update: Generic Duloxetine (Cymbalta) Now Available 


The FDA approved the first generic versions of Cymbalta (duloxetine delayed-release capsules) in December.  As a result, effective December 12, 2013, generic duloxetine is covered at Tier 1 for the 3-Tier formulary and Tier 2 for the 4-Tier formulary, while branded Cymbalta was moved to Tier 3 for the 3-Tier formulary and Tier 4 for the 4-Tier formulary. 

Also, effective January 10, 2014, Harvard Pilgrim has revised our prior authorization guidelines as follows:

  • Coverage of branded Cymbalta requires trial and failure of generic duloxetine
  • Prior authorization criteria for neuropathic pain agents (Lyrica, Savella) now includes generic duloxetine as a first-line therapy
  • Prior authorization criteria for brand name antidepressants now includes generic duloxetine as a first-line therapy

To obtain authorization for branded Cymbalta, please complete the appropriate Medication Request Form and fax it back to MedImpact Healthcare Systems at
888-807-6643.

For more information, visit Harvard Pilgrim’s pharmacy page.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Reminder: Claims for Pediatric Dental Product

CLINICIAN CORNER

Pharmacy Update: Olysio (simeprevir) and Sovaldi (sofosbuvir) Require Prior Authorization

Pharmacy Update: Generic Duloxetine (Cymbalta) Now Available

Suicide Prevention Resources for Providers

OFFICE ASSISTANT

Tips for Submitting Electronic Commercial COB Claims

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator